ArticlePediatric research2025
Decreased endothelial micro-RNA-30b-5p impairs angiogenesis in fetal lambs with persistent pulmonary hypertension.
Article in Pediatric research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Regulatory T cell dysfunction and exhaustion in uveitis: immunometabolic mechanisms, microenvironmental drivers, and emerging therapeutic strategies.Frontiers in immunology · 2026Review
- Deciphering epigenetic control of Notch signaling in persistent pulmonary hypertension of the newborn.Pediatric research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundImpaired angiogenesis contributes to increased pulmonary vascular resistance in persistent pulmonary hypertension of the newborn (PPHN). Notch signaling, critical to lung angiogenesis, is modulated by micro-RNAs (miR). RNA sequencing of pulmonary arterial endothelial cells (PAEC) from a PPHN lamb model revealed downregulated miR-30b-5p.
methodsWe investigated whether decreased levels of miR-30b-5p in PPHN affect angiogenesis by facilitating excess Dll4, a predicted target for miR-30b-5p. We obtained PAEC from a fetal lamb model of PPHN and transfected them with miR-30b-5p mimic and inhibitor. We assessed protein levels by immunoblotting and in vitro angiogenesis by tube formation in Matrigel. We performed In-situ RNA hybridization for in vivo miR-30b-5p levels in the lamb lungs.
resultsPPHN lamb lungs showed decreased miR-30b-5p levels in vivo. PPHN PAEC transfected with miR-30b-5p mimic showed improved capillary tube formation. Control PAEC showed inhibition of tube formation after transfection with miR-30b-5p inhibitor. Transfection with miR-30b-5p led to the downregulation of Dll4, in PPHN PAEC.
conclusionWe conclude that decreased miR-30b-5p in PPHN facilitates overexpression of Dll4, which contributes to impaired angiogenesis in PPHN. MiR-30b-5p improves angiogenesis in PPHN by improving Dll4/Jag1 balance (Jag1, a proangiogenic notch ligand), suggesting an epigenetic role in PPHN. IMPACT: The present study describes a novel mechanism of epigenetic control of impaired angiogenesis in PPHN via miR-30b-5p. The present study also provides new direction for future in vivo studies in animals and patients with PPHN to investigate the role of miR-30b-5p as a biomarker of angiogenesis in PPHN.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.